Abiopharma

Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

Tender/ Acquisition/ Takeover/ Purchase Offer :: Voluntary

Teleflex - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’sHealth Month

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Avanzanite annonce un partenariat paneuropéen avec Agios pour le lancement de PYRUKYND® dans les maladies rares du sang

Cabaletta Bio Announces Proposed Public Offering of Securities

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Insulet - Insulet and Marvel Collaborate to Launch Comic Book Hero with Type 1 Diabetes Featuring Omnipod® 5, Empowering the Diabetes Community Through Representation

Avanzanite gibt europaweite Partnerschaft mit Agios zur Einführung von PYRUKYND® bei seltenen Blutgerinnungsstörungen bekannt